A method for the generation of ectromelia virus (ECTV) recombinants: In vivo analysis of ECTV vCD30 deletion mutants

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Alejo, Ali ^a   Saraiva, Margarida ^b,d   Ruiz Argüello, Maria Begoña ^a   Viejo Borbolla, Abel ^c   de Marco, Mar Fernández ^c,e   Salguero, Francisco Javier ^a,f   Alcami, Antonio ^b,c  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSITY OF MINHO   (Portugal)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD30 LIGAND; DISULFIDE; VIRUS PROTEIN; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ECTROMELIA VIRUS; FATALITY; FEMALE; GENE DELETION; GENE MUTATION; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; MOUSEPOX; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; DISEASE COURSE; GENETIC RECOMBINATION; GENETICS; HUMAN; IMMUNOLOGY; MUTATION; PATHOGENICITY; PROTEIN MULTIMERIZATION; RODENT DISEASE; VIRUS REPLICATION;

ECTROMELIA VIRUS; MURINAE; MUS; VARIOLA VIRUS;

ANIMALS; ANTIGENS, CD30; CELL LINE; DISEASE PROGRESSION; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; FEMALE; HUMANS; LIGANDS; MICE; MICE, INBRED BALB C; MUTATION; PROTEIN MULTIMERIZATION; RECOMBINATION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 65249132922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005175     Document Type: Article

References (59)

1. Moss B (2007) Poxviridae: The Viruses and their replication. In: Knipe DMaH PM, ed. Fields Virology. Fifth Edition ed. Philadelphia: Lippincott Williams & Wilkins. pp 2905-2946.
2. Di Giulio DB, Eckburg PB (2004) Human monkeypox: an emerging zoonosis. Lancet Infect Dis 4: 15-25.
3. Esteban DJ, Buller RM (2005) Ectromelia virus: the causative agent of mousepox. J Gen Virol 86: 2645-2659.
4. Fenner FaB RML (1997) Mousepox. In: Nathanson RA N, Gonzalez-Scarano F, Griffin DE, Holmes KV, Murphy FA, Robinson HL, eds. Viral pathogenesis. Philadelphia, PA: Lippincott-Raven. pp 535-553.
5. Delano ML, Brownstein DG (1995) Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 69: 5875-5877.
6. Fang M, Lanier LL, Sigal LJ (2008) A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog 4: e30.
7. Chaudhri G, Panchanathan V, Buller RM, van den Eertwegh AJ, Claassen E, et al. (2004) Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc Natl Acad Sci U S A 101: 9057-9062.
8. Panchanathan V, Chaudhri G, Karupiah G (2006) Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 80: 6333-6338.
9. Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G (2006) Obligatory requirement for antibody in recovery from a primary poxvirus infection. J Virol 80: 6339-6344.
10. Alcami A, Smith GL (1992) A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71: 153-167.
11. Spriggs MK, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, et al. (1992) Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71: 145-152.
12. Symons JA, Alcami A, Smith GL (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81: 551-560.
13. Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RM (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 270: 15974-15978.
14. Comeau MR, Johnson R, DuBose RF, Petersen M, Gearing P, et al. (1998) A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8: 473-482.
15. Fleming SB, McCaughan CA, Andrews AE, Nash AD, Mercer AA (1997) A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol 71: 4857-4861.
16. Bartlett NW, Dumoutier L, Renauld JC, Kotenko SV, McVey CE, et al. (2004) A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol 85: 1401-1412.
17. Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3: 36-50.
18. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, et al. (2003) Poxviruses and immune evasion. Annu Rev Immunol 21: 377-423.
19. Finlay BB, McFadden G (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767-782.
20. Cunnion KM (1999) Tumor necrosis factor receptors encoded by poxviruses. Mol Genet Metab 67: 278-282.
21. Ruiz-Argüello MB, Alejo A, Alcami A (2005) Secreted tumour necrosis factor inhibitors encoded by poxviruses. In: Digard P, Nash AA, Randall RE, eds. Molecular Pathogenesis of virus infections. Cambridge: Cambridge University Press. pp 269-290.
22. Rahman MM, McFadden G (2006) Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog 2: e4.
23. Brunetti CR, Paulose-Murphy M, Singh R, Qin J, Barrett JW, et al. (2003) A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc Natl Acad Sci U S A 100: 4831-4836.
24. Rahman MM, Barrett JW, Brouckaert P, McFadden G (2006) Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein. J Biol Chem 281: 22517-22526.
25. Alcami A, Khanna A, Paul NL, Smith GL (1999) Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol 80(Pt 4): 949-959.
26. Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, et al. (2006) A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 103: 5995-6000.
27. Hu FQ, Smith CA, Pickup DJ (1994) Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204: 343-356.
28. Loparev VN, Parsons JM, Knight JC, Panus JF, Ray CA, et al. (1998) A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci U S A 95: 3786-3791.
29. Saraiva M, Alcami A (2001) CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J Virol 75: 226-233.
30. Panus JF, Smith CA, Ray CA, Smith TD, Patel DD, et al. (2002) Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc Natl Acad Sci U S A 99: 8348-8353.
31. Saraiva M, Smith P, Fallon PG, Alcami A (2002) Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med 196: 829-839.
32. Demmin GL, Clase AC, Randall JA, Enquist LW, Banfield BW (2001) Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection. J Virol 75: 10856-10869.
33. Falkner FG, Moss B (1990) Transient dominant selection of recombinant vaccinia viruses. J Virol 64: 3108-3111.
34. Sanchez-Puig JM, Blasco R (2000) Puromycin resistance (pac) gene as a selectable marker in vaccinia virus. Gene 257: 57-65.
35. Johnston JB, McFadden G (2004) Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell Microbiol 6: 695-705.
36. Davison AJ, Moss B (1989) Structure of vaccinia virus late promoters. J Mol Biol 210: 771-784.
37. Domi A, Moss B (2002) Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc Natl Acad Sci U S A 99: 12415-12420.
38. Cottingham MG, Andersen RF, Spencer AJ, Saurya S, Furze J, et al. (2008) Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). PLoS ONE 3: e1638.
39. Chen W, Drillien R, Spehner D, Buller RM (1993) In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene. Virology 196: 682-693.
40. Kochneva GV, Urmanov IH, Ryabchikova EI, Streltsov VV, Serpinsky OI (1994) Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence. Virus Res 34: 49-61.
41. Huang J, Huang Q, Zhou X, Shen MM, Yen A, et al. (2004) The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J Biol Chem 279: 54110-54116.
42. Senkevich TG, Koonin EV, Buller RML (1994) A Poxvirus Protein with a RING Zinc Finger Motif Is of Crucial Importance for Virulence. Virology 198: 118.
43. Senkevich TG, Wolffe EJ, Buller RM (1995) Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J Virol 69: 4103-4111.
44. Born TL, Morrison LA, Esteban DJ, VandenBos T, Thebeau LG, et al. (2000) A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J Immunol 164: 3246-3254.
45. Sakala IG, Chaudhri G, Buller RM, Nuara AA, Bai H, et al. (2007) Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J Virol 81: 3346-3353.
46. Xu R-H, Cohen M, Tang Y, Lazear E, Whitbeck JC, et al. (2008) The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J Exp Med: jem.20071854.
47. Wassenaar TA, Quax WJ, Mark AE (2008) The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study. Proteins 70: 333-343.
48. Chan FK (2007) Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37: 101-107.
49. Gileva IP, Nepomnyashchikh TS, Antonets DV, Lebedev LR, Kochneva GV, et al. (2006) Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. Biochim Biophys Acta 1764: 1710-1718.
50. Nuara AA, Walter LJ, Logsdon NJ, Yoon SI, Jones BC, et al. (2008) Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc Natl Acad Sci U S A 105: 1861-1866.
51. Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, et al. (2008) A Novel Role of CD30L/CD30 Signaling by T-T Cell Interaction in Th1 Response against Mycobacterial Infection. J Immunol 181: 6316-6327.
52. Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, et al. (2000) Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J Immunol 165: 786-794.
53. Kennedy MK, Willis CR, Armitage RJ (2006) Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 118: 143-152.
54. Nishimura H, Yajima T, Muta H, Podack ER, Tani K, et al. (2005) A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells. J Immunol 175: 4627-4634.
55. Tulman ER, Delhon G, Afonso CL, Lu Z, Zsak L, et al. (2006) Genome of horsepox virus. J Virol 80: 9244-9258.
56. Alcami A, Smith GL (1996) Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus. Trends Microbiol 4: 321-326.
57. Afonso CL, Delhon G, Tulman ER, Lu Z, Zsak A, et al. (2005) Genome of deerpox virus. J Virol 79: 966-977.
58. Mackett M, Smith GL, Moss B, eds (1985) The construction and characterization of vaccinia virus recombinants expressing foreign genes. Oxford: IRL Press. pp 191-211.
59. Vanderplasschen A, Hollinshead M, Smith GL (1997) Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol 78(Pt 8): 2041-2048.